All Stories

  1. Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
  2. Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy
  3. Current Trends in the Diagnosis, Screening and Treatment of Spinal Muscular Atrophy
  4. Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma
  5. Amphiphilic pH-sensitive polypeptides for siRNA delivery
  6. Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
  7. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
  8. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
  9. Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model
  10. DYNC1H1 gene methylation correlates with severity of spinal muscular atrophy
  11. Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates
  12. Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
  13. Peptide modules for overcoming barriers of nucleic acids transport to cells
  14. Methylation Levels of SLC23A2 and NCOR2 Genes Correlate with Spinal Muscular Atrophy Severity
  15. Development of a receptor-targeted gene delivery system using CXCR4 ligand-conjugated cross-linking peptides
  16. Recent Advances in Gene Therapy of Endometriosis
  17. Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity
  18. Characterization of reducible peptide oligomers as carriers for gene delivery
  19. Towards gene therapy of endometriosis
  20. Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III
  21. A receptor-mediated gene delivery system using CXCR4 ligand-conjugated cross-linking peptides
  22. Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells
  23. Hyper branched polylysines: optimization of DNA bonding, endosomalytic properties and DNA stabilization in the complexes against enzyme hydrolysis
  24. Hyperbranched polylysines modified with histidine and arginine: The optimization of their DNA compacting and endosomolytic properties
  25. Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment
  26. Detection of somatic mosaicism in humans using polymerase chain reaction with random primers
  27. Lysine dendrimers as vectors for delivery of genetic constructs to eukaryotic cells
  28. 202. Effect of Modification with Lipophilic Fragments and Inclusion of Endosomolytic Peptide on Transfection Efficiency Mediated by Lysine Dendrimers*
  29. Optimization of transfection properties of DNA-lysine dendrimer complexes
  30. Cationic oligopeptides modified with lipophilic fragments: Use for DNA delivery to cells
  31. Lysine Dendrimers and Their Starburst Polymer Derivatives: Possible Application for DNA Compaction and in vitro Delivery of Genetic Constructs
  32. Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres
  33. Human Dystrophin Gene Expression in mdx Muscles After In Vivo Ballistic Transfection, Application of Synthetic Oligopeptide Complexes and Cationic Liposomes